Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parentheticals)

v3.23.2
Consolidated Balance Sheets (Parentheticals)
$ in Thousands
Jun. 30, 2023
USD ($)
$ / shares
shares
Jun. 30, 2022
USD ($)
$ / shares
shares
Consolidated Balance Sheets    
Accounts receivable, allowance for doubtful accounts | $ $ 4,738 $ 2,568
Undesignated capital stock, no par (in dollars per share) | $ / shares $ 0 $ 0
Undesignated capital stock, shares authorized (in shares) 5,000,000 5,000,000
Undesignated capital stock, shares issued (in shares) 0 0
Undesignated capital stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) | $ / shares $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 400,000,000 400,000,000
Common stock, shares issued (in shares) 157,641,914 156,644,212
Common stock, shares outstanding (in shares) 157,641,914 156,644,212